aspect of
drug)
→
ReceivesAction
→
determined
| Typicality: | 0.647 |
| Saliency: | 0.551 |
| during clinical trials | 5 | temporal |
| as with any supplement | 4 | other |
| by testing it | 4 | manner |
| effect → be → determined | 39 |
| effect → be → measured | 34 |
| effect → be → calculated | 4 |
| negative | neutral | positive |
| 0.207 | 0.736 | 0.057 |
| Raw frequency | 77 |
| Normalized frequency | 0.551 |
| Modifier score | 1.000 |
| Perplexity | 204.436 |